Mederi Therapeutics

NORWALK, Connecticut, Aug. 11, 2015 /PRNewswire/ — Stretta Therapy, a non-ablative radiofrequency treatment for GERD, was called “effective, safe and durable following 15 years of worldwide use” and cited as a “viable complement or alternative to medical and surgical …

NORWALK, Connecticut, June 17, 2015 /PRNewswire/ – Mederi Therapeutics Inc. today announced that the American Society for Gastrointestinal Endoscopy (ASGE) has issued new Guidelines that cite Stretta as a viable treatment option for GERD. According to the Guidelines, Stretta was …

NORWALK, Connecticut, June 3, 2014 / PRNewswire — An international multi-disciplinary panel of leading gastroenterologists and surgeons addressed the role of Stretta^® in the treatment of gastroesophageal reflux disease (GERD) on May 5 at Digestive Disease Week 2014. The …

NORWALK, Connecticut, May 21, 2014 / PRNewswire — A newly published peer-reviewed study that examines Stretta® therapy, further confirms the long-term effectiveness of this non-surgical treatment for gastroesophageal reflux disease (GERD). The 8-year study published in Gastroenterology Research and …